Squibb K S, Pritchard J B, Fowler B A
J Pharmacol Exp Ther. 1984 Apr;229(1):311-21.
Cadmium metallothionein (CdMT) nephrotoxicity was studied in rats injected i.p. with a single nonlethal dose of CdMT (0.6 mg of Cd per kg). Within 8 hr of CdMT injection, urine volume and urine sodium excretion were increased and sodium dodecyl sulfate gel electrophoresis of urine proteins showed that elevated levels of low molecular weight proteins were present in the urines of CdMT-treated rats. Urine RNAase activity was also elevated, approximately 7-fold, by CdMT but not by zinc metallothionein (ZnMT) or lysozyme at equivalent protein doses, demonstrating that a proteinuria indicative of proximal tubule cell dysfunction develops as an early response to CdMT exposure. Ultrastructural alterations were also present in animals injected with CdMT but not ZnMT or lysozyme. The earliest alterations occurred in the lysosome compartment of the cell. By 1 hr, the number of small lysosomes in renal proximal convoluted tubule cells increased significantly with no changes in other organelle compartments. By 4 and 8 hr, there was a further increase in lysosome number with a concomitant decrease in size and a marked increase in the number of small clear apical vacuoles. Lysosomal cathepsin D activity was decreased at 4 and 8 hr after CdMT injection, and in vitro studies indicated that this effect was not due to a direct inhibition of the enzyme by Cd++ or CdMT. Thus, both lysosome size and protease activity were rapidly altered by CdMT exposure. Studies of Cd binding in the kidney suggest that non-MT-bound Cd is an important factor in CdMT-associated toxicity. Approximately 97% of the Cd present in the cytoplasm at 1 hr was non-MT-bound. Prior induction of renal MT by treatment with zinc (20 mg of Zn per kg as ZnSO4, i.p. 16 hr before CdMT injection) markedly reduced non-MT binding of Cd++ in kidneys of treated animals and inhibited the alterations in urine volume and low molecular weight protein reabsorption induced by CdMT. These data suggest that acute CdMT exposure provides an excellent system for studying the mechanism of cadmium tubular proteinuria and that the intracellular renal MT pool plays a key role in regulating this process.
通过腹腔注射单次非致死剂量的镉金属硫蛋白(CdMT,每千克体重0.6毫克镉)对大鼠的CdMT肾毒性进行了研究。在注射CdMT后的8小时内,尿量和尿钠排泄增加,尿蛋白的十二烷基硫酸钠凝胶电泳显示,CdMT处理的大鼠尿液中低分子量蛋白质水平升高。尿RNA酶活性也因CdMT而升高约7倍,但在同等蛋白质剂量下,锌金属硫蛋白(ZnMT)或溶菌酶则不会使其升高,这表明作为对CdMT暴露的早期反应,出现了指示近端小管细胞功能障碍的蛋白尿。注射CdMT的动物也出现了超微结构改变,但注射ZnMT或溶菌酶的动物未出现。最早的改变发生在细胞的溶酶体区室。到1小时时,肾近端曲管细胞中小溶酶体的数量显著增加,而其他细胞器区室无变化。到4小时和8小时时,溶酶体数量进一步增加,同时大小减小,小而清亮的顶端空泡数量显著增加。CdMT注射后4小时和8小时,溶酶体组织蛋白酶D活性降低,体外研究表明,这种作用不是由于Cd++或CdMT对该酶的直接抑制。因此,CdMT暴露可迅速改变溶酶体大小和蛋白酶活性。对肾脏中镉结合的研究表明,非MT结合的镉是CdMT相关毒性的一个重要因素。1小时时细胞质中约97%的镉是非MT结合的。在用锌(每千克体重20毫克硫酸锌,腹腔注射,在注射CdMT前16小时)处理预先诱导肾脏MT后,显著降低了处理动物肾脏中Cd++的非MT结合,并抑制了CdMT诱导的尿量和低分子量蛋白质重吸收的改变。这些数据表明,急性CdMT暴露为研究镉性肾小管蛋白尿的机制提供了一个极好的系统,并且细胞内肾脏MT池在调节这一过程中起关键作用。